Beam Therapeutics Inc (BEAM)

Finanzdaten der Beam Therapeutics Inc-Aktie (BEAM)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	1,739% 316.19	17.19	20.12	24.21	20.04
Operating Expenses	46.13% 183.33	125.46	122.26	123.14	109.02
Benefits Costs and Expenses	51.86% 172.03	113.28	-	120.67	57.39
Costs And Expenses	51.86% 172.03	113.28	122.26	120.67	57.39
Operating Income/Loss	222.71% 132.86	-108.27	-102.15	-98.93	-88.98
Nonoperating Income/Loss	7.18% 11.30	12.18	19.37	2.468	51.64
Income/Loss Before Equity Method Investments	250.03% 144.16	-96.09	-	-	-37.35
Income/Loss From Continuing Operations Before Tax	250.03% 144.16	-96.09	-82.78	-96.46	-37.35
Income Tax Expense/Benefit	1.366	-	-	-	1.00
Income/Loss From Continuing Operations After Tax	248.61% 142.80	-96.09	-82.78	-96.46	-38.35
Net Income/Loss	248.61% 142.80	-96.09	-82.78	-96.46	-38.35
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	98.42% 1.2492	79.02	76.34	72.27	0.2569
Diluted Average Shares	98.42% 1.2492	79.02	76.34	72.27	0.2569
Basic Earnings Per Share	256.56% 1.91	-1.22	-1.08	-1.33	-0.54
Diluted Earnings Per Share	256.56% 1.91	-1.22	-1.08	-1.33	-0.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-